Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy.

Molecular therapy. Nucleic acids·2023

Same author

The Factory of Blood Production: Hematopoietic Stem Cells.

Methods in molecular biology (Clifton, N.J.)·2022

Same author

Hematopoietic Stem Cell Mobilization: Current Collection Approaches, Stem Cell Heterogeneity, and a Proposed New Method for Stem Cell Transplant Conditioning.

Stem cell reviews and reports·2021

Same author

A Single Radioprotective Dose of Prostaglandin E<sub>2</sub> Blocks Irradiation-Induced Apoptotic Signaling and Early Cycling of Hematopoietic Stem Cells.

Stem cell reports·2020

Same author

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation.

Nature communications·2019

Same author

Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.

Cell·2017

Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026

Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026

Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026

Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026

Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026

Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026

Ver todos los artículos relacionados

Search research articles

Video Experimental Relacionado

Updated: Feb 24, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

Terapia génica para la enfermedad del "niño burbuja"

Jonathan Hoggatt¹

¹Cancer Center and Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA 02129, USA.

|July 16, 2016

Resumen

Este resumen es generado por máquina.

La terapia génica, Strimvelis, trata la inmunodeficiencia combinada grave (ADA-SCID) causada por la deficiencia de adenosina desaminasa. Esta terapia ofrece una opción vital para los pacientes que no tienen un donante de médula ósea.

Más Videos Relacionados

Production and Purification of Baculovirus for Gene Therapy Application

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

Videos de Experimentos Relacionados

Last Updated: Feb 24, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

Production and Purification of Baculovirus for Gene Therapy Application

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

Área de la Ciencia:

Inmunología
La genética
Farmacología

Sus antecedentes:

La deficiencia de adenosina desaminasa (ADA) conduce a la acumulación de metabolitos tóxicos, dañando gravemente el sistema inmunológico.
Esta condición causa inmunodeficiencia combinada severa (ADA-SCID), también conocida como enfermedad de "niño burbuja".

Objetivo del estudio:

Evaluar la eficacia de la terapia génica con Strimvelis para el ADA-SCID.
Proporcionar un tratamiento alternativo para los pacientes con ADA-SCID que carecen de un donante de médula ósea.

Principales métodos:

Utilizando la terapia génica para corregir la deficiencia de ADA.
La administración de Strimvelis a pacientes elegibles para el tratamiento con ADA-SCID.

Principales resultados:

Strimvelis está aprobado por la Agencia Europea de Medicamentos para el tratamiento de ADA-SCID.
La terapia génica ofrece una vía de tratamiento viable para pacientes sin donantes de médula ósea coincidentes.

Conclusiones:

La terapia génica con Strimvelis es un avance significativo en el tratamiento de ADA-SCID.
Este enfoque terapéutico aborda una necesidad crítica no satisfecha de reconstitución inmune en pacientes con ADA-SCID.